NW
Northwest Biotherapeutics, Inc.
NWBO · OTC
$0.16 -1.84% (-$0.00)
1M -7.99%
Market Cap $261.8M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 120.47x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 6.45%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 1,751.63%
Op. margin 2,316.11%
FCF margin 2,224.34%
Quality
0 /100
Poor ROA 50.12%
Asset turnover 0.03x
ROIC 136.63%
Debt
0 /100
High Int. coverage -6.81x
Current ratio 0.04x
Net debt/EBITDA N/A
Stability
48 /100
Moderate Rev. volatility 21.96%
EPS volatility 30.94%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NWBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Linda F. Powers
Employees
105
Headquarters
Bethesda
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report